Prepackaged Foods to Promote Weight Loss

Overweight Clinical Trial

— CHOICES  

Official title:

Randomized Clinical Trial of Portion-Controlled Prepackaged Foods to Promote Weight Loss - CHOICES Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02136290
• Other study ID #: 140047
• Secondary ID: Nestle
• Status: Completed
• Phase: N/A
• First received: January 8, 2014
• Last updated: August 19, 2015
• Start date: May 2014
• Est. completion date: March 2015

Study information

• Verified date: August 2015
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The primary goal of this clinical trial is to examine whether provision of portion-controlled prepackaged foods in the context of a reduced-energy diet prescription and counseling is associated with a greater degree of weight loss at three months in overweight or obese men and women, compared to usual care or control conditions in which the prescribed reduced-energy diet is to be consumed via self-selected foods. The effect on body weight and recognized indicators of disease risk, diet quality and cardiopulmonary fitness, as well as meal satiety and satisfaction, will also be examined. Participants are 184 overweight or obese men and women in San Diego area who will be randomly assigned to usual care or control conditions.

Description:

The first study aim is (1) to test, in a randomized controlled trial, whether provision of portion-controlled prepackaged lunch and dinner entrees in the context of a reduced-energy diet prescription and counseling is associated with a greater degree of weight loss at 12 weeks in overweight or obese men and women, compared to usual care or control conditions in which the prescribed reduced-energy diet is to be consumed via self-selected foods. This study utilizes a randomized study design with participants assigned to the prepackaged food intervention arms or a usual care control group. The second study aim is (2) to describe the effect of participation in the prepackaged food arms (versus control conditions) on circulating lipids (fasting total plasma cholesterol and triglycerides, low-density lipoprotein [LDL] cholesterol, and high-density lipoprotein [HDL] cholesterol), carotenoids (a biomarker of vegetable and fruit intake), C-reactive protein, and cardiopulmonary fitness.

Secondary aims of this study are (3) to describe the association between prepackaged food consumption on meal satiety, eating attitudes and behavior, and meal satisfaction. The hypothesis to be tested is that eating a reduced-energy diet that incorporates unit-defined, prepackaged foods is associated with meal satiety and satisfaction that is superior to a diet based on self-selected foods.

As an exploratory aim, we also will examine whether there is a differential response to different dietary macronutrient composition in the prepackaged food items used in the structured meal plan in intervention participants. Lean Cuisine meal products will be offered to participants assigned to one intervention group, and only Lean Cuisine items with protein contributing >25% energy will be offered to participants in the other intervention group.

Notably, the results of this study may contribute valuable data to the scientific knowledge base regarding the various aspects of diet and diet composition that may promote more successful weight loss. How diet can be best modified to promote weight loss is an important issue currently being considered and debated among clinical and community-based behavioral and nutritional scientists, and the optimal composition for weight loss diets has not been established (IOM 2002). Adherence to any dietary regimen and energy imbalance is a central determinant of successful weight loss, and evidence-based approaches that may promote better adherence with less deprivation and more meal satisfaction could help public health and clinical efforts to reduce the high prevalence of overweight and obesity in the U.S. today.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 184
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 65 Years

Eligibility

Inclusion Criteria:

• overweight or obese men and women

• Aged 25-65 years

• initial BMI >27.0 kg/m2 and < 40 kg/m2

• no eating disorders, food allergies or intolerances

• no history of bariatric surgery

• willing and able to participate in clinic visits and study interactions at specified intervals

• maintain contact with the investigators for at least three months

• willing to allow blood collections

• capable of performing a simple test for assessing cardiopulmonary fitness

Exclusion Criteria:

• inability to participate in physical activity because of co-morbidity or disability (e.g., severe arthritic conditions);

• a history or presence of a comorbid disease for which diet modification and increased physical activity may be contraindicated or complicated;

• self-reported pregnancy or breastfeeding or planning a pregnancy within the next two years;

• currently actively involved in another diet intervention study or organized weight loss program;

• a history or presence of a significant psychiatric disorder or any other condition that, in the investigator's judgment, would interfere with participation in the trial.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Obese
• Overweight
• Weight Loss

Intervention

Behavioral:
• Prepackaged meals
Portion-controlled prepackaged meals
• Usual Care
Usual care dietary counseling

Locations

Country	Name	City	State
United States	University of California, San Diego	La Jolla	California
United States	University of California, San Diego, Moores Cancer Center	La Jolla	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, San Diego	Nestlé

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weight loss		3 months	No